Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support.

From the week of the 9th of September, we are planning to work on 18 projects, including:

Reimbursement

1. Initiating the work on the reimbursement strategy for a number of in-vitro diagnostic tests in the obstetrics and gynecology field in Belgium, Bulgaria, the Czech Republic, France, Germany, Italy, Norway, Romania, and Switzerland
2. Finalizing the reimbursement analysis for an MRI technology in Germany
3. Finalizing the reimbursement analysis for cardiac monitoring solutions in Finland
4. Working on the reimbursement strategy for a neurostimulator in the cardiology field in England, France, and Germany 
5. Finalizing the reimbursement analysis project for four cardiology and peripheral vascular technologies in Italy and Poland
6. Preparing materials for a live virtual educational seminar on market access challenges in Europe for one of the leading med tech companies in Europe
7. Working on the reimbursement analysis for several technologies in ophthalmological, urological, and oncological fields in the Nordic region (Denmark, Finland, Norway, and Sweden)
8. Delivering the reimbursement analysis for in-vitro diagnostic tests in the neonatal and neurovascular field in France and Italy
9. Initiating the work on reimbursement strategy for a medical technology in the urology field in England, France, and Germany
10. Starting a policy analysis project, including qualitative interviews in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 

HEOR

1. Working on the development of a European value dossier for a wound care product
2. Working on the development of a value dossier for a urinary technology in the EMEA region
3. Finalizing the work on adaptations of the health economic model for in-vitro diagnostic test in infectious diseases area in France and Spain
4. Implementing feedback from the client on the policy paper for diabetes technology
5. Finalizing the work the development of the health economic model for technology in the breast cancer space in the UK
6. Working on Evidence Gap Analysis for a neurostimulator in the cardiology field in England, France, Germany, and Italy
7. Initiating work on the development of a health economic model for a neurovascular technology in Belgium, England, France, Germany, Italy and Spain
8. Initiating work on the update of adaptation of the global value dossiers for several technologies in cardio-renal and infectious disease space to European settings

Let us know if you need any market access or HEOR support for your medical technology in Europe.